Price$1.54+0.04 (+3.01%)
01:30 PM07:45 PM
News · 26 weeks69-76%
2026-01-182026-07-12
Mix5090d
- SEC Filings21(42%)
- Insider14(28%)
- Other7(14%)
- Earnings5(10%)
- Leadership3(6%)
Latest news
25 items- PRQTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent DirectorNess Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the "Board") appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (NASDAQ:NNDM), where she led multidisciplinary teams spanning materials, formulations, chemistry, physics, process engineering, mechanics, software, hardware, and electronics. She also co-authored peer-reviewed IEEE research o
- PRNano Dimension Continues Execution of Cost Savings InitiativesWALTHAM, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano," or the "Company") today announced that it has entered into an agreement to terminate the lease for its current corporate headquarters, effective December 31, 2026. As part of its ongoing cost savings initiatives, the current management team successfully negotiated the termination of the long-term lease, originally entered into by MarkForged, Inc. in 2021 and scheduled to expire in 2031, substantially reducing the Company's future lease obligations. The Company previously disclosed that the sale of MarkForged, Inc. was expected to reduce annualized cash burn by approximately $15
- INSIDERChief Executive Officer Stehlin David covered exercise/tax liability with 24,971 units of Ordinary Shares, decreasing direct ownership by 3% to 737,032 units (SEC Form 4) to satisfy withholding obligation4 - Nano Dimension Ltd. (0001643303) (Issuer)
- SECSEC Form 144 filed by Nano Dimension Ltd.144 - Nano Dimension Ltd. (0001643303) (Subject)
- SECSEC Form DEFA14A filed by Nano Dimension Ltd.DEFA14A - Nano Dimension Ltd. (0001643303) (Filer)
- PRNano Dimension Board Sets the Record Straight on Murchinson's Self-Interested and Destructive CampaignIf Murchinson Wins, They Would Control 100% of The Board The Upcoming Extraordinary General Meeting Is Not A Vote On Any Strategic Transaction Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano," or the "Company") today issued the following letter to shareholders regarding its upcoming Extraordinary General Meeting ("EGM") scheduled for July 31, 2026. Nano's Board of Directors (the "Board") urges shareholders to carefully evaluate its recommendations and vote accordingly. Dear Fellow Shareholders: The upcoming Extraordinary General Meeting centers on a fundamental question: should Murchinson Ltd. and certain of its affiliates ("Murchinson") be empowered to take control of yo
- SECSEC Form SCHEDULE 13D filed by Nano Dimension Ltd.SCHEDULE 13D - Nano Dimension Ltd. (0001643303) (Subject)
- SECSEC Form DEFA14A filed by Nano Dimension Ltd.DEFA14A - Nano Dimension Ltd. (0001643303) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Nano Dimension Ltd.SCHEDULE 13D/A - Nano Dimension Ltd. (0001643303) (Subject)
- SECSEC Form DEFA14A filed by Nano Dimension Ltd.DEFA14A - Nano Dimension Ltd. (0001643303) (Filer)
- SECNano Dimension Ltd. filed SEC Form 8-K: Regulation FD Disclosure8-K - Nano Dimension Ltd. (0001643303) (Filer)
- SECSEC Form 425 filed by Nano Dimension Ltd.425 - Nano Dimension Ltd. (0001643303) (Subject)
- PRNano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business CombinationWALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") and Infinite Epigenetics™ ("Infinite Epigenetics," "Infinite") today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson's recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement and are committed to transparency, the final details of the transaction are still being negotiated. However, we would like to address specific questions posed by Murchinson, contextualize the Infinite story and com
- PRMurchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite EpigeneticsBelieves the Proposed Transaction Represents a Misallocation of Corporate Resources That Would Significantly Dilute Existing Shareholders Finds It Deeply Concerning That This Morning's Conference Call Offered Shareholders Little Beyond Buzzwords and Provided No Opportunity to Ask Questions Regarding a Transaction That Materially Impacts the Future of the Company Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term
- SECSEC Form DEFA14A filed by Nano Dimension Ltd.DEFA14A - Nano Dimension Ltd. (0001643303) (Filer)
- SECSEC Form 425 filed by Nano Dimension Ltd.425 - Nano Dimension Ltd. (0001643303) (Subject)
- SECNano Dimension Ltd. filed SEC Form 8-K: Regulation FD Disclosure8-K - Nano Dimension Ltd. (0001643303) (Filer)
- PRNano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics CompanyNano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value CreationProposed Combination Would Deploy Nano Dimension's Capital Base and Nasdaq listing into a High-Growth Healthcare AI OpportunityExisting Nano Shareholders Expected to Retain Meaningful Minority Ownership in Combined Company on a Stated Value for Nano Dimension's Shares that Reflects a 20% Premium to Nano Dimension's Estimated Net Cash at ClosingInfinite Epigenetics Transaction Value of $890 million Infinite Epigenetics Targets a $90B+ U.S. Clinical Diagnostics Market Opportunity Across its Core Disea
- PRMurchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today issued the following letter to Nano shareholders. *** Fellow Nano Shareholders, Over the last few weeks and months, we have heard CEO Dave Stehlin repeatedly say that Nano's Board of Directors (the "Board"), led by Chairman Robert ("Bob") Pons, is evaluating "exciting opportunities" and "very interesting candidates" as potential uses of Nano's "balance sheet, public company platform, and strategic flexibility."1 We believe that
- INSIDERChief Executive Officer Stehlin David covered exercise/tax liability with 19,841 units of Ordinary Shares, decreasing direct ownership by 3% to 762,003 units (SEC Form 4) to satisfy tax liability4 - Nano Dimension Ltd. (0001643303) (Issuer)
- SECSEC Form 144 filed by Nano Dimension Ltd.144 - Nano Dimension Ltd. (0001643303) (Subject)
- SECSEC Form PREC14A filed by Nano Dimension Ltd.PREC14A - Nano Dimension Ltd. (0001643303) (Subject)
- SECSEC Form DEFA14A filed by Nano Dimension Ltd.DEFA14A - Nano Dimension Ltd. (0001643303) (Filer)
- PRNano Dimension Issues Letter from Chief Executive Officer, David StehlinWALTHAM, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano" or the "Company") today issued the following letter to shareholders from Chief Executive Officer, David Stehlin. Dear Fellow Shareholders, I am writing to update you on our progress and on what lies ahead for Nano Dimension. When I became CEO last September, it was clear that the product lines acquired over a number of years under prior leadership did not have the level of integration and synergies required to support sustainable, Company level profitability at scale. Many of these product lines have competitive technologies and talented teams, but without meaningful operating l
- INSIDERDirector Sriubas Andrew was granted 160,000 units of Ordinary Shares, increasing direct ownership by 400% to 200,015 units (SEC Form 4)4 - Nano Dimension Ltd. (0001643303) (Issuer)
NNDM FAQ
5 questionsWhat does Nano Dimension Ltd. do?
Nano Dimension Ltd., together with its subsidiaries, provides additive electronics in Israel and internationally. Its flagship product is the proprietary DragonFly lights-out digital manufacturing (LDM) system, a precision system that produces professional multilayer circuit-boards, radio frequency antennas, sensors, conductive geometries, and molded connected devices for prototyping through custom additive manufacturing. The company also provides nanotechnology based conductive and dielectric inks; and DragonFly and Switch software to manage the design file and printing process. It markets...Where does NNDM stock trade?
Nano Dimension Ltd. (NNDM) is listed on NASDAQ.What sector and industry is NNDM in?
Nano Dimension Ltd. operates in the Technology sector, Electrical Products industry.What companies are similar to NNDM?
Notable peers in the same industry include APH (Amphenol Corporation), ABB (ABB Ltd), TER (Teradyne Inc.), FLEX (Flex Ltd.), CLS (Celestica Inc.). Compare NNDM side-by-side with any of them on Quantisnow.How can I track NNDM on Quantisnow?
Quantisnow aggregates Nano Dimension Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NNDM to receive live email and push alerts on every new disclosure.